載入...
Assessment of blind predictions of the clinical significance of BRCA1 and BRCA2 variants
Testing for variation in BRCA1 and BRCA2 (commonly referred to as BRCA1/2), has emerged as a standard clinical practice and is helping countless women better understand and manage their heritable risk of breast and ovarian cancer. Yet the increased rate of BRCA1/2 testing has led to an increasing nu...
Na minha lista:
| 發表在: | Hum Mutat |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
2019
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6744348/ https://ncbi.nlm.nih.gov/pubmed/31294896 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/humu.23861 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|